Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

Ruan, RW; Li, L; Li, X; Huang, CY; Zhang, ZM; Zhong, HG; Zeng, SC; Shi, QQ; Xia, Y; Zeng, QR; Wen, Q; Chen, JY; Dai, XF; Xiong, JP; Xiang, XJ; Lei, W; Deng, J

Xiang, XJ; Lei, W; Deng, J (通讯作者)，Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China.;Xiang, XJ; Lei, W; Deng, J (通讯作者)，Jiangxi Key Lab lndividualized Canc Therapy, 17 Yongwai St, Nanchang 330006, Jiangxi, Peoples R China.

MOLECULAR CANCER, 2023; 22 (1):

Abstract

BackgroundFibroblast growth factors (FGFs) and their receptors (FGFRs) play a crucial role in cell fate and angiogenesis, with dysregulation of the si......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索